Drug Type Prophylactic vaccine |
Synonyms M2SR-vectored bivalent vaccine, SARS-CoV-2 M2SR |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | United States | 21 Feb 2023 | |
Influenza, Human | Preclinical | United States | 21 Feb 2023 |